Dare Bioscience, Inc. - 8-K Filing
Dare Bioscience completed closings of its Regulation A offering on May 1, 2026, and subsequent dates, issuing 195,010 Investor Units at $5.00 per unit. Each unit included one share of Series A Convertible Preferred Stock and two warrants to purchase one share of common stock, for total proceeds of $975,050.
Tickers: $DARE